rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Brent M. Longnecker

Director

Company insider

Files Form 4 as: Director, Genprex; Director, AmREIT; Director, Atp Oil & Gas.

In numbers

Trades disclosed
45
Buys
14
Sells
2
Bought
$685K
Sold
$181K
Companies
3
Companies where not an officer
3
First trade
24 Nov 2009
Last trade
14 Apr 2026
Last filed
15 Apr 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
GNPX GenprexDirector · Biotechnology · last 14 Apr 20261 buy · 1 sell
AmREITDirector · last 18 Feb 201512 buys · 0 sells
Atp Oil & GasDirector · last 11 Oct 20121 buy · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
14 Apr 2026filed 15 Apr 2026GNPX GenprexBiotechnologySEC FORM 4 Sold$108 at $1.23filing
14 Apr 2026filed 15 Apr 2026GNPX GenprexBiotechnologySEC FORM 4 Sold$1210 at $1.23filing
14 Apr 2026filed 15 Apr 2026GNPX GenprexBiotechnologySEC FORM 4 Sold$108 at $1.23filing
14 Apr 2026filed 15 Apr 2026GNPX GenprexBiotechnologySEC FORM 4 Sold$1210 at $1.23filing
22 Dec 2025filed 23 Dec 2025GNPX GenprexBiotechnologySEC FORM 4 Code A—9,000 at $0.00filing
5 Dec 2024filed 6 Dec 2024GNPX GenprexBiotechnologySEC FORM 4 Code A—4,750 at $0.00filing
27 Jun 2023filed 29 Jun 2023GNPX GenprexBiotechnologySEC FORM 4 Code A—123,795 at $0.00filing
23 Jun 2022filed 27 Jun 2022GNPX Genprexoption or derivative · BiotechnologySEC FORM 4 Code A—83,368 at $0.00filing
24 Jun 2021filed 25 Jun 2021GNPX Genprexoption or derivative · BiotechnologySEC FORM 4 Code A—32,376 at $0.00filing
5 Apr 2021filed 7 Apr 2021GNPX GenprexBiotechnologySEC FORM 4 Bought$62K15,000 at $4.15filing
24 Jul 2020filed 28 Jul 2020GNPX Genprexoption or derivative · BiotechnologySEC FORM 4 Code A—42,068 at $0.00filing
18 Feb 2015filed 18 Feb 2015AmREITSEC FORM 4 Code D$2.6M99,094 at $26.55filing
23 Jun 2014filed 24 Jun 2014AmREITSEC FORM 4 Bought$4,508250 at $18.03filing
23 Jun 2014filed 24 Jun 2014AmREITSEC FORM 4 Bought$41K2,250 at $18.04filing
10 Jun 2014filed 11 Jun 2014AmREITSEC FORM 4 Bought$121K6,733 at $17.94filing
28 May 2014filed 29 May 2014AmREITSEC FORM 4 Code A—1,735filing
5 May 2014filed 6 May 2014AmREITSEC FORM 4 Bought$10K600 at $17.00filing
5 May 2014filed 6 May 2014AmREITSEC FORM 4 Bought$24K1,400 at $16.83filing
4 Mar 2014filed 5 Mar 2014AmREITSEC FORM 4 Bought$27K1,500 at $17.94filing
21 Feb 2014filed 21 Feb 2014AmREITSEC FORM 4 Bought$20K1,200 at $16.75filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care2
Not placed14

Buys in green, sells in red, by the company’s sector.

Related people

Mark Stanley BergerChief Medical Officer · Chief Medical Officer at Genprex, filing Form 4 there in the last year
Ryan M. ConferPresident, CEO and CFO · President, CEO and CFO at Genprex, filing Form 4 there in the last year